
Jonathan Block
Managing Editor, Sectors at Seeking Alpha
Managing Editor, Sectors and Senior Health Care News Editor at Seeking Alpha. MPH from CUNY Graduate School of Public Health. All opinions are mine.
Articles
-
1 week ago |
seekingalpha.com | Jonathan Block
-
1 week ago |
seekingalpha.com | Jonathan Block
Zerbor Veeva Systems is up ~15% in post-market trading Wednesday after boosting its fiscal year 2026 revenue and EPS projections. The provider of cloud-based software for the life sciences industry now sees revenue for the year of between $3.09B and $3.1B compared to $3.04B-$3.055B
-
1 week ago |
seekingalpha.com | Jonathan Block
Phira Phonruewiangphing/iStock via Getty Images The U.S. FDA has granted approval to Alcon's (NYSE:ALC) Tryptyr (acoltremon ophthalmic solution) for Dry Eye Disease. Tryptyr is a first-in-class TRPM8 receptor agonist that works by stimulating corneal sensory nerves to increase natural tear production. Approval was based on
-
1 week ago |
seekingalpha.com | Jonathan Block
Suriphon Singha/iStock via Getty ImagesHealthcare technology company Tempus AI (NASDAQ:TEM) has dropped ~19% following a short report issued by Spruce Point Capital Management issued on Wednesday morning. Seeking Alpha has reached out to Tempus AI seeking comment. Tempus AI has a short interest of 11.29%.
-
1 week ago |
seekingalpha.com | Jonathan Block
May 28, 2025 10:29 AM ET, , , , , , , , , , By: , SA News EditorEmilija Randjelovic/iStock via Getty ImagesThe U.S. Court of Appeals for the First Circuit on Tuesday issued an opinion that repudiated arguments from marijuana businesses that operate legally on the state level who were seeking to have federal prohibition of cannabis overturned. A panel ofSymbolLast Price% Chg--Green Thumb Industries Inc. --Curaleaf Hldgs Inc. --Amplify Alternative Harvest ETF--Trulieve Cannabis Corp.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 449
- Tweets
- 872
- DMs Open
- No

Yet another interesting development involving @CassavaSciences #Alzheimers #CUNY Interesting that $SAVA shares up 12% in Tuesday afternoon trading. https://t.co/cHMREionxh

Exciting news for @GEHealthCare and @VUMCDiscoveries, and promising for using #ai to improve health outcomes for #cancer patients. https://t.co/3necZyZqtn

Antibody-drug conjugates, a relatively new type of cancer treatment, are poised to boost the bottom lines on several pharma and biotech companies. https://t.co/BQPaw7U4Ny